Bullous pemphigoid after anti–programmed death-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes
Caroline A. Nelson, Sean Singer, Tianqi Chen, Ashleigh Eberly Puleo, Christine G. Lian, Erin X. Wei, Anita Giobbie‐Hurder, Arash Mostaghimi, Nicole R. LeBoeuf
Topics & Concepts
MedicinePembrolizumabBullous pemphigoidRetrospective cohort studyVitiligoDermatologyAdverse effectInternal medicinePemphigoidCancerMelanomaAntibodyImmunologyImmunotherapyCancer researchAutoimmune Bullous Skin DiseasesCancer Immunotherapy and BiomarkersMelanoma and MAPK Pathways